Skip to Main Content
Skip Nav Destination

Apremilast is an inhibitor of Phosphodiesterase type 4 an enzyme which breaks down cyclic adenosine monophosphate while using the treatment of Psoriasis and arthritis. This is one of advanced oral drug with low side effects as comparatively other psoriatic drugs like adalimumab, etanercept, infliximab, ustekinumab, secukinumab, and cyclosporine.

This content is only available via PDF.
You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal